Despite Hsp90’s role in these processes, clinical trials for pan Hsp90 inhibitors to treat cancer unfortunately were not successful, primarily due to Hsp90’s essential cellular functions such as homeostasis etc. leading to massive side-effects. This evidence concerns the gene HSP90AA1 and cancer.